BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5011 related articles for article (PubMed ID: 31401318)

  • 1. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Systems Pharmacology, Urinary Metabonomics, and Quantitative Real-Time PCR Analysis to Uncover Targets and Metabolic Pathways of the You-Gui Pill in Treating Kidney-Yang Deficiency Syndrome.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the biomarkers and therapeutic mechanism of kidney-yang deficiency syndrome treated by You-gui pill using systems pharmacology and serum metabonomics.
    Chen R; Wang J; Liao C; Zhang L; Guo Q; Wang X
    RSC Adv; 2018 Jan; 8(2):1098-1115. PubMed ID: 35539000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the intervention effect of Epimedium before and after suet-oil-processed on kidney yang deficiency rats based on intestinal flora and fecal metabolomics.
    Huang R; Chen Z; Ding K; Sun E; Huang Y; Wei Y; Jia X
    J Pharm Biomed Anal; 2024 Mar; 240():115957. PubMed ID: 38181555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites.
    Xiao S; Liu C; Chen M; Zou J; Zhang Z; Cui X; Jiang S; Shang E; Qian D; Duan J
    Appl Microbiol Biotechnol; 2020 Jan; 104(1):303-317. PubMed ID: 31758238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated UHPLC-MS untargeted metabolomics and gut microbe metabolism pathway-targeted metabolomics to reveal the prevention mechanism of Gushudan on kidney-yang-deficiency-syndrome rats.
    Xin L; Ren M; Lou Y; Yin H; Qin F; Xiong Z
    J Pharm Biomed Anal; 2024 May; 242():116062. PubMed ID: 38387127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chinmedomics strategy to discover effective constituents and elucidate action mechanism of Nanshi capsule against kidney-yang deficiency syndrome].
    Liu Q; Zhao HW; Zhang AH; Sun H; Zhao XH; Nan Y; Kong L; Guan Y; Zou SY; Ma ZH; Wang XJ
    Zhongguo Zhong Yao Za Zhi; 2016 Aug; 41(15):2901-2914. PubMed ID: 28914036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics.
    Yu M; Jia H; Zhou C; Yang Y; Zhao Y; Yang M; Zou Z
    J Pharm Biomed Anal; 2017 May; 138():231-239. PubMed ID: 28219800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary and Fecal Metabonomics Study of the Protective Effect of Chaihu-Shu-Gan-San on Antibiotic-Induced Gut Microbiota Dysbiosis in Rats.
    Yu M; Jia HM; Zhou C; Yang Y; Sun LL; Zou ZM
    Sci Rep; 2017 Apr; 7():46551. PubMed ID: 28425490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Integrated Fecal Microbiome and Metabolomics in T2DM Rats Reveal Antidiabetes Effects from Host-Microbial Metabolic Axis of EtOAc Extract from
    Shao J; Liu Y; Wang H; Luo Y; Chen L
    Oxid Med Cell Longev; 2020; 2020():1805418. PubMed ID: 32566075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic profiling reveals therapeutic biomarkers of processed Aconitum carmichaeli Debx in treating hydrocortisone induced kidney-yang deficiency syndrome rats.
    Tan Y; Liu X; Lu C; He X; Li J; Xiao C; Jiang M; Yang J; Zhou K; Zhang Z; Zhang W; Lu A
    J Ethnopharmacol; 2014 Mar; 152(3):585-93. PubMed ID: 24556226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis.
    Ye JZ; Li YT; Wu WR; Shi D; Fang DQ; Yang LY; Bian XY; Wu JJ; Wang Q; Jiang XW; Peng CG; Ye WC; Xia PC; Li LJ
    World J Gastroenterol; 2018 Jun; 24(23):2468-2481. PubMed ID: 29930468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined systems pharmacology and fecal metabonomics to study the biomarkers and therapeutic mechanism of type 2 diabetic nephropathy treated with
    Chen R; Liao C; Guo Q; Wu L; Zhang L; Wang X
    RSC Adv; 2018 Jul; 8(48):27448-27463. PubMed ID: 35540008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal 16S rRNA Gene Sequencing Analysis of Changes in the Gut Microbiota of Rats with Low-Dose Aspirin-Related Intestinal Injury.
    Chi T; Zhao Q; Wang P
    Biomed Res Int; 2021; 2021():8848686. PubMed ID: 33954200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated fecal microbiome and metabolome in the aged mice reveal anti-aging effects from the intestines and biochemical mechanism of FuFang zhenshu TiaoZhi(FTZ).
    Shenghua P; Ziqin Z; Shuyu T; Huixia Z; Xianglu R; Jiao G
    Biomed Pharmacother; 2020 Jan; 121():109421. PubMed ID: 31743877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive fecal metabolomics and gut microbiota for the evaluation of the mechanism of Panax Ginseng in the treatment of Qi-deficiency liver cancer.
    Hou Z; Song F; Xing J; Zheng Z; Liu S; Liu Z
    J Ethnopharmacol; 2022 Jun; 292():115222. PubMed ID: 35341933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative Analysis of Gut Microbiota and Fecal Metabolites in Rats after Prednisone Treatment.
    Zhang J; Feng D; Law HK; Wu Y; Zhu GH; Huang WY; Kang Y
    Microbiol Spectr; 2021 Dec; 9(3):e0065021. PubMed ID: 34756061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zengye decoction induces alterations to metabolically active gut microbiota in aged constipated rats.
    Liu D; Lin L; Lin Y; Zhong Y; Zhang S; Liu W; Zou B; Liao Q; Xie Z
    Biomed Pharmacother; 2019 Jan; 109():1361-1371. PubMed ID: 30551387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiome and Serum Metabolome Alterations Associated with Isolated Dystonia.
    Ma L; Keng J; Cheng M; Pan H; Feng B; Hu Y; Feng T; Yang F
    mSphere; 2021 Aug; 6(4):e0028321. PubMed ID: 34346706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.
    Liu Y; Li J; Yu J; Wang Y; Lu J; Shang EX; Zhu Z; Guo J; Duan J
    J Pharm Biomed Anal; 2018 Feb; 149():425-435. PubMed ID: 29169110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 251.